RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Total Assets
Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) holds total assets worth €7.98 Billion EUR (≈ $9.33 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of RENAU.UNSP.ARD 1/5 EO-20 for net asset value and shareholders' equity analysis.
RENAU.UNSP.ARD 1/5 EO-20 - Total Assets Trend (2022–2025)
This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's total assets have evolved over time, based on quarterly financial data.
RENAU.UNSP.ARD 1/5 EO-20 - Asset Composition Analysis
Current Asset Composition (December 2025)
RENAU.UNSP.ARD 1/5 EO-20's total assets of €7.98 Billion consist of 18.1% current assets and 82.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.3% |
| Accounts Receivable | €179.80 Million | 2.3% |
| Inventory | €690.90 Million | 8.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.54 Billion | 19.3% |
| Goodwill | €2.88 Billion | 36.1% |
Asset Composition Trend (2022–2025)
This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is RENAU.UNSP.ARD 1/5 EO-20 worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RENAU.UNSP.ARD 1/5 EO-20's current assets represent 18.1% of total assets in 2025, a decrease from 33.0% in 2022.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 2.1% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 39.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 36.1% of total assets.
RENAU.UNSP.ARD 1/5 EO-20 Competitors by Total Assets
Key competitors of RENAU.UNSP.ARD 1/5 EO-20 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Autek China Inc
SHE:300595
|
China | CN¥6.42 Billion |
|
Kestra Medical Technologies, Ltd. Common Stock
NASDAQ:KMTS
|
USA | $246.70 Million |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
AVE Science & Technology Co Ltd
SHG:688067
|
China | CN¥611.46 Million |
|
M.I.TECH Co.Ltd
KQ:179290
|
Korea | ₩134.55 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
RENAU.UNSP.ARD 1/5 EO-20 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.02 | 1.85 | 2.14 |
| Quick Ratio | 0.53 | 1.12 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €29.10 Million | €802.20 Million | €862.60 Million |
RENAU.UNSP.ARD 1/5 EO-20 - Advanced Valuation Insights
This section examines the relationship between RENAU.UNSP.ARD 1/5 EO-20's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.81 |
| Latest Market Cap to Assets Ratio | 2.06 |
| Asset Growth Rate (YoY) | -3.3% |
| Total Assets | €7.98 Billion |
| Market Capitalization | $16.46 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values RENAU.UNSP.ARD 1/5 EO-20's assets at a significant premium (2.06x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: RENAU.UNSP.ARD 1/5 EO-20's assets decreased by 3.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)
The table below shows the annual total assets of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €7.98 Billion ≈ $9.33 Billion |
-3.30% |
| 2024-12-31 | €8.26 Billion ≈ $9.65 Billion |
+6.81% |
| 2023-12-31 | €7.73 Billion ≈ $9.04 Billion |
+52.61% |
| 2022-12-31 | €5.07 Billion ≈ $5.92 Billion |
-- |
About RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more